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ABSTRACT
Introduction: Up to 70% of children with attention-
deficit/hyperactivity disorder (ADHD) experience sleep
problems. We have demonstrated the efficacy of a brief
behavioural intervention for children with ADHD in a
large randomised controlled trial (RCT) and now aim to
examine whether this intervention is effective in real-life
clinical settings when delivered by paediatricians or
psychologists. We will also assess the cost-
effectiveness of the intervention.
Methods and analysis: Children aged 5–12 years
with ADHD (n=320) are being recruited for this
translational cluster RCT through paediatrician
practices in Victoria and Queensland, Australia.
Children are eligible if they meet criteria for ADHD,
have a moderate/severe sleep problem and meet
American Academy of Sleep Medicine criteria for either
chronic insomnia disorder or delayed sleep–wake
phase disorder; or are experiencing sleep-related
anxiety. Clinicians are randomly allocated at the level of
the paediatrician to either receive the sleep training or
not. The behavioural intervention comprises 2
consultations covering sleep hygiene and standardised
behavioural strategies. The primary outcome is change
in the proportion of children with moderate/severe
sleep problems from moderate/severe to no/mild by
parent report at 3 months postintervention. Secondary
outcomes include a range of child (eg, sleep severity,
ADHD symptoms, quality of life, behaviour, working
memory, executive functioning, learning, academic
achievement) and primary caregiver (mental health,
parenting, work attendance) measures. Analyses will
address clustering at the level of the paediatrician
using linear mixed effect models adjusting for potential
a priori confounding variables.
Ethics and dissemination: Ethics approval has been
granted. Findings will determine whether the benefits of
an efficacy trial can be realised more broadly at the
population level and will inform the development of
clinical guidelines for managing sleep problems in this
population. We will seek to publish in leading
international paediatric journals, present at major
conferences and through established clinician networks.
Trial registration number: ISRCTN50834814,
Pre-results.
INTRODUCTION
Sleep problems are common and more per-
sistent in children with attention-deﬁcit/
hyperactivity disorder (ADHD), and asso-
ciated with poorer child and family well-
being.1–4 Efﬁcacy randomised controlled
trials (RCTs) have shown that sleep problems
are amenable to intervention5–10 in children
with ADHD, particularly behavioural inter-
ventions.8–10 However, it is unknown whether
the same beneﬁts will be observed when
such interventions are delivered by practi-
tioners in ‘real life’ clinical settings. This
article describes the protocol for the
Sleeping Sound with ADHD Translational
RCT, which aims to assess the effectiveness of
Strengths and limitations of this study
▪ First translational trial to determine whether a
brief, behavioural sleep intervention has benefits
for children with attention-deficit/hyperactivity
disorder (ADHD) when delivered in ‘real-life’ clin-
ical settings by paediatricians and psychologists.
▪ The inclusion of blinded teacher reports, as well
as blinded direct assessment measures to min-
imise bias.
▪ Inclusion of economic analyses, which provide
data on the cost-effectiveness of the programme.
▪ Limited generalisability to non-English-speaking
families and children with ADHD presenting with
serious medical conditions and/or intellectual
disability.
▪ Sleep problems assessed using non-blinded
parent report as opposed to objective measures.
Sciberras E, et al. BMJ Open 2017;7:e014158. doi:10.1136/bmjopen-2016-014158 1
Open Access Protocol
group.bmj.com on April 11, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
a behavioural sleep intervention designed for children
with ADHD, when delivered by psychologists or paedia-
tricians in their daily clinical practice.
Sleep problems in children with ADHD
Up to 70% of children with ADHD experience sleep
problems,1 2 compared with 20–30% of children in the
general population.11 Sleep problems experienced by
children with ADHD largely comprise difﬁculties initiat-
ing and/or maintaining sleep, with the most common
sleep problems being difﬁculty falling asleep (reported
by 84% of parents of children who report a sleep
problem for their child with ADHD), bedtime resistance
(68%), tiredness on waking (62%) and difﬁculty waking
in the morning (56%).2 Medical conditions such as
obstructive sleep apnoea (OSA) can also affect sleep in
children with ADHD, although behavioural sleep pro-
blems appear more common.12 In this study, we use the
term sleep problems to denote those difﬁculties that can
be addressed using behavioural intervention. Sleep pro-
blems have been associated with worse functioning for
children with ADHD, including poorer quality of life
(QoL), behaviour, daily functioning and working
memory, as well as increased school absenteeism.2 4 13
They thus represent an important modiﬁable target for
intervention.
A number of factors have been associated with sleep
problems in children with ADHD and it is possible that
biological sleep problems such as restless legs syndrome,
OSA and narcolepsy can lead to continued sleep disrup-
tions.12 Insomnia can be a side effect of stimulant medi-
cation,1 14 although unmedicated children with ADHD
also experience higher rates of sleep problems relative
to non-ADHD controls.15 Comorbid externalising and
internalising comorbidities are each associated with a
twofold increase in moderate/severe sleep problems in
children with ADHD, while co-occurring internalising
and externalising comorbidities are associated with a
threefold increase.16 Parenting inconsistency in daily
household routines has also been associated with
increased bedtime resistance in this group.17
Biologically, there is overlap in the brain regions and
genetic factors (eg, catecholaminergic system, CLOCK
genes) associated with ADHD and sleep disorders/
arousal regulation.1 ADHD is also a highly genetic con-
dition and parents likely are affected by symptoms such
as disorganisation and impulsivity, which may impact on
child sleep.
Treating sleep problems in children with ADHD using
behavioural strategies
We recently published our efﬁcacy RCT evaluating the
impact of a behavioural sleep programme in children
with ADHD and moderate/severe sleep problems
(n=244 children aged 5–12 years with ADHD).8
Children were recruited from 21 paediatric practices
across Victoria, Australia, and randomised to either a
behavioural sleep intervention (n=122) or a usual care
comparison group (n=122). Intervention families
attended 2× 50 min individual sessions (held 2 weeks
apart) with a clinician trained in the intervention
(psychologist or trainee paediatrician), comprising a
standardised yet ﬂexible intervention, tailored to the
child’s sleep problems and family preferences.
The intervention was associated with improved child
outcomes at 3 and 6 months postrandomisation, includ-
ing improved parent-reported child sleep, ADHD
symptom severity, QoL, daily functioning and behav-
iour.8 Intervention children also had improved teacher-
reported classroom behaviour, as well as improved
school attendance and working memory assessed via
blinded assessment.8 There were small improvements in
sleep duration for a subsample that completed actigra-
phy.8 Although the intervention was associated with
improved caregiver work attendance and mental health
3 months later, these beneﬁts were not observed at
6 months.8
Similarly, two additional RCTs have demonstrated the
efﬁcacy of improving sleep problems in children with
ADHD. Keshavarzi et al9 reported that a 12-week sleep
training programme for children with ADHD aged
10 years (n=40) had beneﬁcial effects for sleep and psy-
chosocial functioning when compared with controls with
ADHD who did not receive the intervention (n=20) and
typically developing children (n=20). However, the pro-
fessional group responsible for delivering the interven-
tion was not reported. Corkum et al10 also recently
reported the beneﬁcial effects of their distance sleep
intervention delivered by paraprofessionals for child-
hood insomnia in a mixed sample of children with and
without ADHD (n=61). Improvements were identiﬁed at
2 and 6 months for sleep assessed using parent report as
well as actigraphy, and beneﬁts were also reported for
broader child psychosocial health.10
Although RCTs have shown that melatonin is asso-
ciated with improved sleep onset latency for children
with ADHD,5–7 broader beneﬁts for daily functioning
including ADHD symptom severity have yet to be shown.
Managing sleep problems in children with ADHD through
existing clinical services
Although three trials have now shown that it is possible
to improve sleep problems in children with ADHD using
behavioural approaches, it remains to be seen whether it
is possible to replicate such approaches and improve
outcomes for children with ADHD in ‘real life’ clinical
settings when delivered by their treating clinicians (eg,
community paediatricians or psychologists) rather than
by clinicians hired to deliver interventions in tightly con-
trolled research trials. We are now testing the translation
of this programme at the population level by training
community paediatricians and psychologists to deliver
this sleep intervention to children with ADHD and sleep
problems. If this intervention can be translated success-
fully to the population level within existing workforces,
then this would have the real potential to improve
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outcomes for children with ADHD and their families. If
cost-effective, it could be readily incorporated into the
existing health system.
Paediatricians are the main care providers for ADHD
in Australia.18 The paediatrician’s role includes the
assessment and treatment (behavioural and medication-
based) of ADHD and associated comorbidities (includ-
ing sleep problems, if identiﬁed). Visits to a paediatrician
are subsidised by Australia’s Medicare scheme; however,
families may experience out-of-pocket costs for these
visits. Paediatricians (and general practitioners) may also
refer children to a psychologist in the community to
manage comorbid behaviours.19 In Australia, this referral
is facilitated by the Medicare Better Access to Mental
Health Scheme, which provides subsidised access to up
to 10 psychology sessions in a calendar year, provided the
criteria for a DSM condition are met. We have deliber-
ately designed our sleep intervention, so that it is feasible
for paediatricians and psychologists to deliver within
the Australian Medicare scheme and within their typical
consultation durations.
Aims and hypotheses
Building on our efﬁcacy trial, we aim to determine
whether the Sleeping Sound with ADHD intervention,
delivered by paediatricians or psychologists in their
usual work setting, can replicate the beneﬁts of the efﬁ-
cacy trial. Therefore, in this translational, cluster-
randomised trial, we aim to determine whether a brief
sleep intervention delivered by paediatricians or
psychologists:
1. Decreases the prevalence of children with moderate/
severe sleep problems from moderate/severe to no/
mild by parent report at 3 months postintervention
(primary outcome).
2. Improves child and family functioning at 3 and
6 months postintervention (secondary outcome).
3. Is cost-effective (secondary outcome).
We hypothesise that, compared with the control chil-
dren at 3 months (primary outcome timepoint) and
6 months postintervention, a brief behavioural sleep
intervention will:
1. Decrease the prevalence of child sleep problems
from moderate/severe to no/mild;
2. Improve functioning in other child (sleep severity,
ADHD symptoms, QoL, behaviour, working memory,
executive functioning, learning, academic achieve-
ment, school attendance) and primary caregiver
(mental health, parenting, work attendance)
outcome domains.
3. Be cost-effective.
METHODS AND ANALYSIS
Overall study design
This is a cluster RCT of a behavioural sleep intervention
versus usual care conducted in Victoria and
Queensland, Australia (see ﬁgure 1). The trial will be
reported according to Consolidated Standards of
Reporting Trials guidelines and the extension report of
non-pharmacological interventions.20
Participants
Participants are parents of children aged 5–12 years at
the time of recruitment with paediatrician-diagnosed
and DSM-5 conﬁrmed ADHD and a moderate to severe
sleep problem as deﬁned by the American Academy of
Sleep Medicine diagnostic criteria:21 chronic insomnia
disorder, delayed sleep–wake phase disorder or
sleep-related anxiety.
Recruitment of health professionals
Given that paediatricians are the main healthcare pro-
vider for children with ADHD, recruitment and random-
isation occurs at the level of the paediatrician.
Paediatricians are recruited via the Australian Paediatric
Research Network or through clinical contacts.18
Interested paediatricians are invited to attend a brieﬁng
session in which the study requirements and timetable is
presented and paediatricians have the opportunity to
ask questions. Interested paediatricians are sent a
follow-up email thanking them for their interest, asking
them to sign an individual Memorandum of
Understanding (MOU) if they consent to participation,
and asking them to provide a list of psychologists to
whom they refer patients. By signing the MOU, paedia-
tricians agree to: (1) participate in training if rando-
mised to the intervention arm; (2) deliver the sleep
programme to intervention families or refer the child to
a psychologist to deliver the sleep programme if allo-
cated to the intervention; (3) not share the intervention
materials with control group paediatricians if allocated
to the intervention; and (4) allocate time for interven-
tion session bookings.
Once paediatricians have been recruited, psychologists
are invited to whom the paediatricians have indicated
they refer patients. Psychologists are only recruited for
the intervention arm of the project and have no contact
with control participants. The research team then
informs psychologists about the study via email or
phone. The researchers then send psychologists who
express interest in participating a follow-up email thank-
ing them for their interest and asking them to sign an
individual MOU, agreeing to: (1) participate in training;
(2) deliver the sleep programme to intervention families
referred by paediatricians; (3) use intervention materials
only with children enrolled in the study; and (4) not
share the intervention materials with any other families
they see during the study period. This approach has
worked well to minimise contamination in our previous
RCTs.22–24
Screening children for sleep problems and recruiting
families
This translational trial uses, where possible, the same
procedures that were used in our efﬁcacy trial.8
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Paediatricians preidentify their patients with ADHD,
aged between 5 and 12 years, seen within the last
12 months, either through their medical software or
through case notes. Paediatricians then send a letter to
the child’s primary caregiver inviting them to take part.
The letter advises families that the research team will ask
them about their child’s sleep and ADHD symptoms. An
‘opt out’ approach is used, whereby parents are asked to
Figure 1 Participant flow.
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contact the paediatrician if they do not wish to learn
more about the study. If parents do not opt out within a
2-week period, the paediatrician provides the research
team with the contact details of the families. Only 9% of
families opted out in our efﬁcacy trial.8 Paediatricians
also have the option to use an active consent process. In
these cases, paediatricians send an ‘opt in’ version of
the study invitation letter.
The research team then contacts interested (or not
opted-out) families via telephone to ascertain if the
child meets inclusion/exclusion criteria. Eligible fam-
ilies are sent a parent information statement and
consent form (to participate in the RCT and for
optional consents outlined below) and a baseline
survey. Families have the option to complete hard copy
surveys or online surveys (via REDCap—a secure,
web-based application).25 Surveys are completed by the
child’s primary caregiver. Parents have the option to
consent to have their child’s school teacher complete a
survey about their child’s behaviour. If consent is pro-
vided by the primary caregiver and school, a link to an
online survey is sent to teachers. Parents also have the
option to consent to being contacted for ethically
approved future research, for the research team to keep
their deidentiﬁed data to be shared with future ethically
approved research, and to allow the research team to
link with their child’s National Assessment Program—
Literacy and Numeracy (NAPLAN) results. NAPLAN is
a national assessment of literacy and numeracy
Australian children complete in Grades 3 and 5, and
years 7 and 9.26
Once caregivers provide written consent, the research
team contacts them to complete the Anxiety Disorders
Interview Schedule for Children (ADIS-C) over the tele-
phone to assess comorbid internalising and externalising
diagnoses in children with ADHD.27 To ensure we
administer the telephone interviews consistently, we are
recording 10% of the sample to test inter-rater
reliability.
Inclusion/exclusion criteria (all assessed via telephone)
Inclusion criteria
A. Child aged between 5 and 12 years at the time of the
recruitment call.
B. Child’s sleep is a moderate–severe problem for the
caregiver ascertained using the following question:
‘Has your child’s sleep been a problem for you over
the past 4 weeks?’ If ‘yes’, they are asked to rate sever-
ity (mild, moderate or severe). This measure has
been used in studies of children with and without
ADHD and has good agreement with the Children’s
Sleep Habits Questionnaire.2 28 29
C. Child sleep problem meets the International
Classiﬁcation of Sleep Disorders—Third Edition cri-
teria21 for an eligible sleep disorder (chronic insom-
nia disorder, delayed sleep–wake phase disorder) or
sleep-related anxiety assessed using study-designed
questions. To meet criteria for chronic insomnia
disorder in this study, children need to meet criterion
A (one or more of the following: difﬁculty initiating
sleep, difﬁculty maintaining sleep, waking earlier
than desired, resistance going to bed, difﬁculty sleep-
ing without a caregiver), B (evidence of impairments
related to the sleep difﬁculty such as daytime sleepi-
ness, impaired social, family, or academic perform-
ance, etc), C (sleep problem not be explained by
inadequate sleep opportunity or circumstances) and
D and E (symptoms and associated impairment must
have been present three times a week or more for at
least 3 months).21 To meet criteria for delayed sleep–
wake phase disorder in this study, criterion A (signiﬁ-
cant phase delay as shown by difﬁculty initiating
sleep and awakening at a required time), B (delayed
sleep–wake phase must have been present for at least
3 months) and C (improved sleep quality and dur-
ation when allowed to choose their own schedule)
need to be satisﬁed.21 Children were accepted into
the study on the basis of experiencing sleep-related
anxiety if the caregiver endorses signiﬁcant difﬁculty
falling asleep at night, in addition to anxious behav-
iour at bedtime (eg, fearful behaviours such as
crying, asking for reassurance or lying in bed
worrying).
D. Child meets DSM 5 criteria for ADHD assessed via the
18-item ADHD Rating Scale IV—a validated scale
measuring the core symptoms of ADHD.30 Caregivers
need to rate at least six of nine of the inattention
and/or hyperactivity/impulsivity items as occurring
‘often’ or ‘very often’ in order to meet current
symptom criteria. Caregivers are asked to rate symp-
toms of stimulant medication. Additional questions
are then asked to ensure symptoms have been present
for at least 6 months (‘Did your child have these symp-
toms for at least 6 months before being diagnosed
with ADHD?), and contribute to cross-situational
impairment (‘Are these symptoms present at home,
school and/or when out socially?’). Given the target
age range, all participants will meet age of onset cri-
teria. We do not assess whether the symptoms were
better explained by another mental disorder.
Children are eligible to participate if they are taking
melatonin or any other sleep-inducing medication, as
long as the inclusion criteria are still met, despite medi-
cation use.
Exclusion criteria
A. Suspected OSA identiﬁed using three OSA items
from the Children’s Sleep Habits Questionnaire.31
Paediatrician investigators HHi and HHe telephone
caregivers of children with suspected OSA to ask
further about their symptoms and if OSA is sus-
pected, these children are excluded and referred to
appropriate clinical services as per usual clinical care
(1% in our efﬁcacy trial).8
B. No longer meeting criteria for ADHD at the time of
recruitment.
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C. Major illness or disability (eg, intellectual disability).
Parents are asked if their child has ever been diag-
nosed with an intellectual disability or serious
medical condition. If yes, parents are asked to
provide further details (eg, IQ score, diagnosis). If
clariﬁcation is needed, permission is sought to recon-
tact the paediatrician to obtain relevant information
from the child’s medical record. Common comorbid-
ities, including internalising/externalising disorder
and autism spectrum disorder, are not excluded.
D. Parents with insufﬁcient English language proﬁciency
to complete study documentation and/or participate
in the intervention.
E. Participated in our original efﬁcacy trial.
Sample size
Sample size planning is based on the primary outcome,
the proportion of children for whom parents no longer
report moderate/severe sleep problems at 3 months. In
the efﬁcacy study, at 3 months, 56% and 30% of parents
in the intervention and control group, respectively,
reported that their child’s sleep was still a moderate/
severe problem, that is, a difference of 26%. We conser-
vatively assume a smaller difference of 20%, that is, 56%
vs 36% to be observed in this trial. In order to have 80%
power in detecting this difference at a two-sided type 1
error level of 5%, a group sample size of 107 individuals
(total sample size n=214) is required. As this is a cluster
controlled trial (clustered at the level of the paediatrician
to minimise contamination), we will inﬂate our sample
size by a design effect of 1.2 where the design effect=1
+(n−1)r with n=3 (the number of children seen by each
paediatrician) and r=0.1 (the conservatively assumed
intracluster correlation coefﬁcient, based on our efﬁcacy
RCT). Allowing for 20% drop out to 3 months and
accounting for clustering, we need to recruit 160 chil-
dren in each study arm (total sample size n=320). All
recruitment procedures described have been used in our
previous trials to achieve similar recruitment numbers.
Randomisation
Randomisation occurs at the level of the paediatrician.
Paediatricians are randomly allocated to either receive
the sleep training or not by an independent researcher,
thereby avoiding potential contamination if all paediatri-
cians were to be trained in the programme.
Randomisation is based on a pregenerated group alloca-
tion sequence from the Murdoch Childrens Research
Institute’s Clinical Epidemiology and Biostatistics Unit
and is stratiﬁed by location of the paediatrician
(regional or metropolitan area). The randomisation is
also stratiﬁed by the predicted number of enrolled
patients (<10 and 10 or more). Paediatricians, families
and researchers are blind to group allocation at the time
of recruitment.
If the paediatrician is assigned to the intervention
group and has more than four patients enrolled, fam-
ilies are randomised to receive the intervention from
either the paediatrician or psychologist. This second
step of randomisation takes place after family recruit-
ment is complete. The research team then sends the
paediatrician a letter informing them of whether they
will be receiving the sleep training or not. In addition,
participating families are also sent a letter informing
them of whether they will be receiving the sleep inter-
vention or not.
Families of children attending a paediatrician rando-
mised to the control group receive ‘usual care’ which
involves seeing their paediatrician as per usual regarding
their child’s ADHD. Our research has shown that this
does not routinely include addressing sleep issues.2 In
Australia, paediatricians typically see children with
ADHD every 6 months to check their height, weight,
blood pressure and reissue a script for medication (valid
for 6 months), where necessary.
Intervention training
The intervention is designed to be feasible to deliver in
paediatricians’ and psychologists’ practice. Intervention
group paediatricians and psychologists are trained to
deliver the same programme described for our efﬁcacy
trial8 in one 3.5 hour session. Training occurs conjointly
for paediatricians and psychologists, where possible, with
investigators HHi, ES and HHe to maximise ﬁdelity.
Training addresses normal sleep patterns in school-aged
children and highlights the importance of sleep hygiene
practices such as consistent bedtime routines and
keeping bedrooms media-free. The intervention includes
verbal and written information of standard sleep inter-
vention strategies as recommended by the American
Sleep Association32 and addresses common sleep pro-
blems experienced at the beginning of, and during, the
night. A summary of sleep problems addressed and man-
agement strategies are provided in table 1. Training
focuses on how these strategies can be individualised for
families and includes evidence-based instructional strat-
egies such as role play, feedback, modelling practice and
use of checklists. Training is supported by a manual and
written parent education materials.
Prior to training, paediatricians and psychologists com-
plete a ‘pre-quiz’ to establish their baseline knowledge,
skills and attitudes in relation to child sleep problems
and their management. A ‘post-quiz’ following training
is used to assess changes in knowledge, conﬁdence and
perceived competence in the management of child
sleep problems.
Intervention delivery
Paediatricians and psychologists are sent an intervention
package for each child allocated to them containing the
child’s contact details, a clinical checklist to complete
after each appointment and parent education materials.
Families contact the clinician they have been allocated to
make an appointment (up to 30 min for paediatricians,
up to 50 min for a psychologist) to discuss their child’s
sleep, with a follow-up session (up to 30 min for
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paediatricians, up to 50 min for a psychologist) ∼2 weeks
later and if needed, a ﬁnal 15–20 min phone call a
further 2 weeks after that. The differences in consultation
duration reﬂect real-life clinical practice. We record the
actual duration of all consultations, which will enable us
to examine the relationship between intervention dose
and outcomes. Children are present at all face-to-face
appointments. The ﬁrst session focuses on an assessment
of the child’s sleep problem, providing information
about normal sleep and sleep cycles, giving the family a
sleep diary to complete, advice about sleep hygiene and a
plan speciﬁcally tailored to the child’s particular sleep
disorder. The second session and follow-up phone call
include a review of the sleep diary, re-enforcement/
trouble shooting of existing strategies and the introduc-
tion of new strategies, where appropriate.
The research team contacts families within 1 month
postrandomisation to ensure an appointment has been
made with either their paediatrician or a psychologist
and to encourage them to make the appointment if they
have not yet performed so.
Follow-up
We mail/email follow-up surveys to families and teachers
at 3 and 6 months postintervention (measured from ﬁrst
intended intervention session for intervention families
with controls followed up at the median date of interven-
tion follow-up) to determine short and longer term
changes in primary and secondary outcomes. Teachers
are not informed of the child’s intervention group
status. For intervention families only, the 3-month survey
also asks about the behavioural intervention components
received, usefulness of the intervention, ease of use of
strategies, costs experienced by families in accessing the
programme and any negative events/experienced. At
6 months, a trained research assistant completes a
blinded direct assessment of child executive functioning,
learning, working memory, academic functioning, sleep
and QoL via home visits (of 45 min duration).
Measures
All measures administered at baseline, 3 and 6 months
are summarised in table 2. The majority of measures
were used in our efﬁcacy trial. We now additionally
measure academic functioning, given that our efﬁcacy
trial showed a trend towards improvement in working
memory, which is a key determinant of academic func-
tioning. For similar reasons, we also include a more
detailed assessment of cognitive and executive function-
ing. The baseline questionnaire includes family (eg,
family composition, parental education and age, lan-
guage spoken at home, annual household income) and
Table 1 Key behavioural sleep management strategies
Sleep disorder Definition Examples of behavioural strategies
Sleep-onset
association
disorder
Child associates falling asleep with a
person or object (eg, television) and is
unable to fall asleep without its presence
▸ Adult fading (ie, graduated extinction) using ‘camping
out’—gradual withdrawal of parental presence from the
child’s bedroom over 7–10 days
▸ ‘Checking method’—parent checks on the child at
regular time intervals (2, 5 or 10 min, with intervals
increasing over time)
Delayed sleep
phase
Shift in the child’s sleep–wake cycle, in
which the child cannot fall asleep until late
and then wakes late in the morning
▸ Bedtime fading—child’s bedtime is temporarily set later
to when they are usually falling asleep and gradually
brought forward. The child is then woken at a preset
time in the morning
▸ Early morning light exposure
Limit setting
sleep disorder
Child refusal to go to bed and general
non-compliant behaviour at bedtime. Parent
struggles to set appropriate and consistent
bedtime limits
▸ Parent management strategies—ignoring child protests,
rewarding compliance with bedtime routines. A ‘bedtime
pass’, whereby the child can only leave the bedroom
one time before sleep, can be used to promote
compliant behaviour
▸ Consideration of bedtime fading or the checking method
Primary insomnia Child has substantial difficulty initiating and/
or maintaining sleep even if they go to bed
at a later time
▸ Visual imagery and relaxation
▸ Basic cognitive restructuring
▸ Restricting time in bed (eg, temporarily setting the
bedtime later as per delayed sleep phase or getting out
of bed and doing a relaxing activity if the child cannot
sleep)
Night-time
anxiety
Specific night-time fears including fear of
the dark and/or child worrying about other
things while in bed
▸ Visual imagery and relaxation training
▸ Discussing fears during the day rather than just before
bedtime
▸ Rewarding brave behaviour
▸ Other—use of a security object, avoiding scary
television shows, use of a book to record worries
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child demographic and medical (eg, medication, diag-
nosed comorbidities, etc) characteristics.
The research team prospectively records resources
used to administer all programme components to facili-
tate economic analyses. Families also report time, travel
and out-of-pocket costs associated with visits as well as
those costs associated with child ADHD medication/
prescriptions.
Data analysis
Primary (aim 1) and secondary (aim 2) analyses will be
based on the ‘intention to treat’ population at the level
of the individual child and will adjust for clustering at
the level of the paediatrician using a generalised linear
mixed effect model (logit link function) for the binary
primary outcome (proportion of children with moder-
ate/severe sleep problems). For primary and secondary
Table 2 Summary of measures
Construct Measures Source T1 T2 T3
Child outcomes
Sleep Sleep problem prevalence (primary outcome)—Primary caregiver report of child
sleep problem (none/mild vs moderate/severe)2
P ● ● ●
Children’s Sleep Habits Questionnaire (CSHQ)—33-item validated measure of
disorders of initiating and maintaining sleep.31 Child Sleep Self-Report collected
at 6 months only15
P ● ● ●
Teacher Daytime Sleepiness Questionnaire—10-item validated scale of daytime
sleepiness at school39
T ● ● ●
Sleep Hygiene scale—7-item measure assessing sleep hygiene24 P ● ●
Comorbidity Anxiety Disorders Interview Schedule for DSM-IV (ADIS-C)—diagnostic interview
assessing mental health disorders according to DSM-IV criteria. This is
completed with parents over the telephone and has been validated for this
purpose27
P ●
ADHD ADHD Rating Scale IV—18-item validated scale measuring the core symptoms
of ADHD30
P, T ● ● ●
Behaviour Strengths and Difficulties Questionnaire—25 items assessing the following
subscales: hyperactivity/inattention, conduct problems, emotional symptoms,
peer relationship problems, and prosocial behaviour40
P, T ● ● ●
Irritability Affective reactivity index (ARI)—6-item validated measure assessing child
irritability41
P ● ● ●
School
attendance
School attendance over the preceding 3 months2 P ● ● ●
Quality of life Child Health Utility-9D (CHU-9D)—9-item measure of child quality of life used to
calculate quality-adjusted life years. Child report is collected at the 6-month
follow-up only42
P, C ● ●
Pediatrics Quality of Life Inventory 4.0–23-item measure of child total, physical
and psychosocial QoL43
P ● ●
Memory Sleep Suite App—An animated iPad application that includes a continuous
performance test to measure sustained attention, and 2 tests of memory
consolidation and learning44
C ●
Working Memory Working Memory Test Battery for Children—The Backward digit span recall
subtest is administered as a measure of child working memory45
C ●
Academic
functioning
Wide Range Achievement Test 4 (WRAT)—word reading and math computation
subtests46
C ●
NAPLAN—standardised academic tests of reading, writing, language
conventions and numeracy. Results can be compared with National or State
population results and against the national minimum standard26
L ●
Autism Social Responsiveness Scale (SRS) Brief—16-item measure of autism spectrum
disorder symptoms47
P ●
Parent outcomes
Mental health Kessler 6 (K6)—6-item validated measure of adult psychological stress48 P ● ● ●
Work attendance Work attendance over the previous 3 months2 P ● ● ●
Parenting Parenting—validated scales developed for the Longitudinal Study of Australian
Children assessing parenting consistency (6 items) and parental warmth (5
items)49
P ● ●
Family costs Service use and costs—families report service use over previous 3 months as
well as time, travel and out-of-pocket costs associated
P ● ●
C, child-report; L, data linkage; P, parent-report; T, teacher-report; T1, baseline; T2, 3 months postintervention; T3, 6 months postintervention.
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analyses, the stratiﬁcation variable ‘location of study site
(practice)’ as well as an indicator variable for the type of
healthcare professional who delivered the intervention
(paediatrician or psychologist) will be considered as
adjustments variables. For all analyses, model-based
effect estimates (risk differences and risk ratios) will be
reported along with 95% CIs. Because of the range of
outcomes and timepoints, the results will be considered
in their totality and interpreted with suitable caution
regarding formal conclusions of ‘statistical signiﬁcance’.
In order to reduce potential confounding bias due to
differential patient-drop out over time, multiple imput-
ation methodology will be considered to replace missing
outcome data in the primary efﬁcacy analysis. All sec-
ondary analyses (aim 2) will be adjusted for baseline
scores and stratiﬁcation variables wherever possible, in
order to increase precision of comparisons.33 For
primary and secondary analyses, we will present results
of analyses unadjusted and adjusted for further potential
outcome predictor variables (child age, medication use,
comorbidities, and family sociodemographic character-
istics (Socioeconomic Index for Advantage linked to the
family’s postcode),34 parent high school completion and
parent age). Syntax will be written before database lock,
which will cover the primary and secondary analyses.
Participant-level data are available on request.
Cost-effectiveness analyses
The economic analysis (aim 3) will ﬁrst present cost-
consequences analysis, then proceed to cost-effectiveness
analysis against the primary outcome (prevalence of sleep
problems) measure as the primary economic analysis.
Secondary economic analyses will include cost-utility
analysis against CHU9D-based QALYs.35 36 These ana-
lyses will be conducted from the healthcare and broader
societal perspectives (as cost-effectiveness can vary sig-
niﬁcantly by perspective)37 and will include extensive
sensitivity analyses to test the impact of uncertainty in
data and sensitivity to evaluation approach.
DISSEMINATION
ADHD affects ∼5% of school-aged children38 and is fre-
quently associated with sleep problems, which worsen
child and family outcomes.2 Findings will determine
whether the beneﬁts of an efﬁcacy trial can be realised
more broadly at the population level and whether it is
cost-effective to do so. If cost-effective, we expect the fol-
lowing outcomes: (1) the best evidence yet that addres-
sing sleep problems improves outcomes for children
with ADHD; and (2) a ready-to-use intervention that is
tailored to the Australian health system, and can be
replicated internationally. Findings will inform the devel-
opment of clinical guidelines for managing sleep pro-
blems in this population. We will seek to publish in
leading international paediatric journals, present at
major conferences and disseminate ﬁndings through
established clinician networks.
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and Medical Research Council of Australia (1106427).
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